Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122999813 | 12299981 | 3 | F | 20160622 | 20160425 | 20160721 | EXP | US-ACTAVIS-2016-08275 | ACTAVIS | KHAWAJA MR, MINTURN JT, SPITTLER AJ, CHIOREAN EG. OCULAR METASTASIS OF COLORECTAL CANCER: AN UNCOMMON PRESENTATION OF A COMMON MALIGNANCY. HEMATOL ONCOL STEM CELL THER. 2015;8(4):176-80 | 60.00 | YR | F | Y | 0.00000 | 20160721 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122999813 | 12299981 | 1 | PS | ELOXATIN | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | FOLFOX, 1/TWO WEEKS | UNCONFIRMED | 78803 | UNK | QOW | |||||||
| 122999813 | 12299981 | 2 | SS | ELOXATIN | OXALIPLATIN | 1 | 78803 | UNK | |||||||||||
| 122999813 | 12299981 | 3 | C | 5-FLUOROURACIL /00098801/ | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | FOLFOX, 1/TWO WEEKS | 0 | QOW | |||||||||
| 122999813 | 12299981 | 4 | C | 5-FLUOROURACIL /00098801/ | FLUOROURACIL | 1 | 0 | ||||||||||||
| 122999813 | 12299981 | 5 | C | LEUCOVORIN /00566701/ | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | FOLFOX, 1/TWO WEEKS | U | 0 | QOW | ||||||||
| 122999813 | 12299981 | 6 | C | LEUCOVORIN /00566701/ | LEUCOVORIN | 1 | U | 0 | |||||||||||
| 122999813 | 12299981 | 7 | C | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | UNK, 1/TWO WEEKS | 0 | QOW | |||||||||
| 122999813 | 12299981 | 8 | C | AVASTIN | BEVACIZUMAB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122999813 | 12299981 | 1 | Colorectal cancer metastatic |
| 122999813 | 12299981 | 2 | Metastases to eye |
| 122999813 | 12299981 | 3 | Colorectal cancer metastatic |
| 122999813 | 12299981 | 4 | Metastases to eye |
| 122999813 | 12299981 | 5 | Colorectal cancer metastatic |
| 122999813 | 12299981 | 6 | Metastases to eye |
| 122999813 | 12299981 | 7 | Colorectal cancer metastatic |
| 122999813 | 12299981 | 8 | Metastases to eye |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122999813 | 12299981 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122999813 | 12299981 | Hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122999813 | 12299981 | 1 | 201012 | 0 | ||
| 122999813 | 12299981 | 3 | 201012 | 0 | ||
| 122999813 | 12299981 | 5 | 201012 | 0 | ||
| 122999813 | 12299981 | 7 | 201012 | 0 |